Compare Top Brokerages Here. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. MarketBeat just released five new trading ideas, but CRISPR Therapeutics wasn't one of them. On average, they anticipate CRISPR Therapeutics' share price to reach $141.79 in the next twelve months. What happens next will shock you…". Size, Drivers, Trends & Forecast 2025. View analyst ratings for CRISPR Therapeutics or view top-rated stocks. View CRISPR Therapeutics' earnings history. Detail Earnings Estimate History contains forecast … Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. CRISPR Therapeutics had a negative trailing twelve-month return on equity of 20.72% and a negative net margin of 273.10%. ... (GLOBE NEWSWIRE) -- The "Procurement Software Market - Growth, Trends, Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The move came on solid volume too with far more shares changing hands than in a normal session. You can opt out at any time. Receive a free world-class investing education from MarketBeat. CRISPR Therapeutics AG Stock Price Forecast, "CRSP" Predictons for2025 ... CRISPR Therapeutics AG Stock Forecast and Price Prognosis Data for 2025 . *Stock price forecasts are predicted by Deep Learning processes by technical analysis, shouldn't been used for investment decision. In addition, the company is developing allogeneic CAR-T programs comprising CTX120 targeting B-cell maturation antigen for the treatment of multiple myeloma; and CTX130 for the treatment of solid tumors and hematologic malignancies. What Makes CRISPR Therapeutics AG (CRSP) a New Buy Stock. Vote “Underperform” if you believe CRSP will underperform the S&P 500 over the long term. Start Now for $1 >>, Jessica Silver-Greenberg and Michael Corkery. The CRSP/COMPUSTAT Merged Database allows for concurrent database access to CRSP’s stock data and Compustat’s fundamental data. In that case, its stock would basically be worthless. HOME MARKET TRADE PRICING DOWNLOAD HELP. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . View our full suite of financial calendars and market data tables, all for free. "StockInvest.us" is a research service that provides financial data and technical analysis of publicly traded stocks. CRISPR (CRSP) to Report Q4 Earnings: What's in the Cards? Some companies that are related to CRISPR Therapeutics include Biogen (BIIB), Seagen (SGEN), BioNTech (BNTX), Novozymes A/S (NVZMY), Novavax (NVAX), argenx (ARGX), Bio-Techne (TECH), QIAGEN (QGEN), Repligen (RGEN), Neurocrine Biosciences (NBIX), Adaptive Biotechnologies (ADPT), Fate Therapeutics (FATE), Vir Biotechnology (VIR), Twist Bioscience (TWST) and Denali Therapeutics (DNLI). ), CRISPR Therapeutics has received 339 “underperform” votes. Their forecasts range from $21.00 to $72.50. Please log in to your account or sign up in order to add this asset to your watchlist. Only 17.10% of the stock of CRISPR Therapeutics is held by insiders. Introducing CRISPR Therapeutics (NASDAQ:CRSP), The Stock That Soared 424% In The Last Three Years - Simply Wall St - October 18th, 2020 CRISPR And CRISPR-Associated (Cas) Genes Market Break Down by Top Companies, Countries, Applications, Challenges, Opportunities and Forecast … MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Form 4 or Form 5 obligations may continue. As of 2021 February 10, Wednesday current price of SSYS stock is 53.105$ and our data indicates that the asset price has been stagnating for the past 1 year (or since … CRSP | Complete CRISPR Therapeutics AG stock news by MarketWatch. CRISPR Therapeutics has a P/B Ratio of 9.46. CRISPR Therapeutics AG has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. CRISPR Therapeutics does not have a long track record of dividend growth. CRISPR Therapeutics AG Stock Forecast. 06:58 AM ET. 5 days ago JS predicted that CRSP for Feb. 1st is going $166.34 (-1.46%) 6 days ago Cesar predicted that CRSP for Feb. 1st is going Rank: 1 week ago JS predicted that CRSP … Feb 04, 2021 (AmericaNewsHour) -- Global Genome Editing Market - Drivers, Restraints, Opportunities, Trends, and Forecast, 2019-2025… This means that this stock is suited as a new addition to your portfolio as trading bullish markets is always a lot easier. Based on an average daily trading volume, of 1,920,000 shares, the days-to-cover ratio is presently 1.5 days. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing. © American Consumer News, LLC dba MarketBeat® 2010-2021. 16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CRISPR Therapeutics in the last twelve months. Zgutowicz predicts that by year-end, 12% of Shopify's North American revenue will be coming from SFN, driving 21% gains for the stock. Lightning fast & can cost as Little as 5¢ or even 1¢...", Co-Founder & Scientific Advisory Board Member, Scientific Founder & Advisory Board Member, Start Your Risk-Free Trial Subscription Here, 3 Consumer Discretionary Stocks Ready to Run, 3 Dating App Stocks for Investors to Love, Fox hosts Dobbs, Bartiromo strike back in voting fraud suit, Georgia governor urges Biden to block battery maker penalty, Amazon sues NY attorney general to stop virus probe, General Motors settles with California for $5.75M, 3 Oil & Gas Stocks Worth Watching in 2021, U.S. Steel Stock is an Economic Recovery Buy Here, American Axle Manufacturing Stock is an Automotive Recovery and Electrification Play, 3 Health Care Stocks That Could Double by Year End, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, Interesting CRSP Put And Call Options For April 1st, Bear of the Day: CRISPR Therapeutics (CRSP), Meridian Bioscience, CRISPR Therapeutics, Tilray and Uber highlighted as Zacks Bull and Bear of the Day, CRISPR Therapeutics to Participate in the Guggenheim Healthcare Talks 2021 Oncology Day.